Navigation Links
Ikaria® Names New Chief Financial Officer
Date:7/8/2010

CLINTON, N.J., July 8 /PRNewswire/ -- Ikaria, Inc. today announced that Craig Tooman will join Ikaria as Senior Vice President and Chief Financial Officer (CFO).  In this role, Mr. Tooman will be responsible for all financial functions of the company, as well as for information technology services.  Mr. Tooman succeeds Elizabeth Larkin, who left the company in March to pursue other interests.  He will assume his new role at the beginning of August.

"I am delighted that Craig will join us in this key executive role, and am confident that we will benefit greatly from his knowledge and experience in effectively managing the financial aspects of our business," commented Daniel Tasse, Chairman and CEO of Ikaria. "I believe that Craig's expertise -- combined with our product pipeline and commercial capabilities -- will help us achieve our vision of becoming a leader in critical care.  I also wish to thank Liz for building a strong foundation from which we can build."

Mr. Tooman has over 20 years of experience in the pharmaceutical industry, and joins Ikaria from Enzon Pharmaceuticals, where he was Executive Vice President of Finance and CFO since 2005.  Prior to joining Enzon, he served as Senior Vice President of Strategic Planning and Corporate Communications at ILEX Oncology, Inc., which was acquired by Genzyme in 2004.  He also played a significant role in the 2001 merger between Pharmacia & Upjohn and Monsanto that created the Pharmacia Corporation, having served in various positions within its predecessor companies Pharmacia & Upjohn and The Upjohn Company.  Mr. Tooman holds an MBA from the University of Chicago, and a BA from Kalamazoo College.

About Ikaria, Inc.

Ikaria, Inc. is a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to address the significant unmet needs of critically ill patients.  The company's lead product is INOtherapy®, an all-inclusive offering of drug product, services and technologies.  INOMAX® (nitric oxide) for inhalation, the drug included in the INOtherapy offering, is the only FDA-approved drug for the treatment of hypoxic respiratory failure associated with pulmonary hypertension in term and near-term infants.  INOtherapy also is marketed in Puerto Rico, Canada, Australia, Mexico and Japan.  Ikaria acquired the North American and Australian rights to LUCASSIN® (terlipressin), a potential treatment for hepatorenal syndrome Type 1, as well as the exclusive worldwide license to IK-5001, a potential treatment for preventing cardiac remodeling and subsequent congestive heart failure following acute myocardial infarction.  The company also has a number of investigational compounds in development.  Ikaria is headquartered in Clinton, NJ, with research facilities in Seattle, WA and Madison, WI, and a manufacturing facility in Port Allen, LA.  Please visit www.ikaria.com.


'/>"/>
SOURCE Ikaria, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
2. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
3. Xytis Names Gordon H. Busenbark as Chief Financial Officer
4. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
5. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
6. California Cryobank Names Richard Jennings President of FamilyCord Division
7. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
8. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
9. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
10. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
11. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
Breaking Medicine News(10 mins):